MAOA and prostate carcinoma: MAO-A knockdown in different prostate cancer cell lines counteracted the above-mentioned mechanisms and significantly attenuated EMT in vitro, while in prostate cancer xenograft mouse models, both MAO-A knockdown as well as inhibition through clorgyline reduced tumor growth [33].